<DOC>
	<DOCNO>NCT02629432</DOCNO>
	<brief_summary>The main objective trial prove MRI - image modality without use ionizing radiation - replace CT structural functional regional phenotyping COPD . The identification different COPD phenotype , `` emphysema-type '' `` airway-type '' , important therapy prognosis different . The medical problem address trial image-based phenotyping COPD . The sensitivity specificity MRI compare Lowdose-CT serve gold standard . MRI CT lung perform multi-centre cohort 625 COPD-patients main COSYCONET cohort . The reliability MRI result demonstrate . MRI phenotype evaluate visually use software quantitative read-out . The agreement determine . The additional information MRI CT assess .</brief_summary>
	<brief_title>Image-Based Structural Functional Phenotyping COSYCONET Cohort Using MRI CT</brief_title>
	<detailed_description>This prospective trial aim phenotype COPD use Imaging methods.The identification different COPD phenotype , `` emphysema-type '' `` airway-type '' , important therapy prognosis different . Imaging might play central role diagnose phenotype . So far computed tomography ( CT ) regard gold standard , involve ionize radiation lack functional information . The medical problem address trial image-based phenotyping COPD . The principal research question whether magnetic resonance imaging ( MRI ) replace CT characterization COPD `` structural functional phenotyping '' regional basis . The sensitivity specificity MRI compare CT serve gold standard . To achieve goal , MRI CT lung perform multi-centre cohort 625 COPD-patients main Cosyconet cohort . Also , reliability MRI result demonstrate . MRI phenotype evaluate visually use software quantitative read-out . The agreement determine . The additional information MRI CT assess . A special focus implement image-based biomarker pulmonary functional reserve derive MRI measurement pulmonary perfusion , correlate result pulmonary function test ( e.g . lung transfer factor carbon monoxide ( TLCO ) ) 6-minute walk test ( 6-MWD ) , extrapulmonary disease manifestation .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>The population study determined main Cosyconetcohort . Key inclusion criterion : include main cohort diagnosis COPD ( GOLD criterion ) availability repeat study visit male female age &gt; 40 year Key exclusion criterion determine main Cosyconetcohort : undergone lung surgery ( e.g. , lung volume reduction , lung transplant ) moderate severe exacerbation within last 4 week prior visit 1 unable understand intention project lack sign patient inform consent contraindication MRI pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>MRI</keyword>
	<keyword>COPD</keyword>
</DOC>